Wednesday, June 10, 2026

pharma Β· Nonalcoholic Steatohepatitis (NASH) Β· Amyotrophic Lateral Sclerosis Β· CORT

CORCEPT THERAPEUTICS

CORCEPT THERAPEUTICS clinical programs β€” 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

101 Redwood Shores Pkwy, Redwood City, California 94065, US HQ
1998 Founded
756 Employees
Public company Type
CORT Β· NYSE Ticker
Company details
Status
Public
HQ
101 Redwood Shores Pkwy, Redwood City, California 94065, US
Founded
1998
Employees
756
Programs
67
Drugs
36
Patents
120
Intelligence Β· Clinical Programs

CORCEPT THERAPEUTICS projects

1 ClinicalTrials.gov programs sponsored by CORCEPT THERAPEUTICS.

CORCEPT THERAPEUTICS has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Mifepristone 300 MG [Korlym]

    CORCEPT THERAPEUTICS INC

    Hypercortisolism

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does CORCEPT THERAPEUTICS have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.